Linezolid is an oxazolidinone antibiotic used for treating serious gram-positive infections, including drug-resistant strains like MRSA and VRE. It inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Linezolid is valuable for hospital-acquired infections and is available both orally and intravenously.